B． 议程项目4：审议技术和经济评估小组2007年进度报告中论及的下列各项议题
Agenda item 4: Consideration of issues arising out of the 2007 progress report of the Technology and Economic Assessment Panel
4．技术和经济评估小组将介绍其2007年进度报告。
The Technology and Economic Assessment Panel will deliver a presentation of its 2007 progress report.
1． 议程项目4(a): 审查2008 和2009年必要用途豁免提名
Item 4 (a): Review of nominations for essential-use exemptions for 2008 and 2009
5．依照第IV/25号决定，共有三个缔约方—欧洲共同体、俄罗斯联邦和美利坚合众国分别提交了其2008和2009年度计量吸入器所用氟氯化碳的必要用途豁免申请。
In accordance with decision IV/25, three Parties, the European Community, the Russian Federation and the United States of America, submitted requests for essential-use exemptions for chlorofluorocarbons (CFCs) for metered-dose inhalers applicable to the years 2008 and 2009.
下表概要介绍了技术和经济评估小组针对这些申请提出的相关建议 。
The following tables outline the recommendations of the Technology and Economic Assessment Panel related to these requests.
表 1: 非第5条缔约方2007年度必要用途提名（公吨）
Table 1: Essential-use nominations in metric tonnes for non-Article 5 Parties for 2007
6．技经评估组在就上述各项提名作出的建议中指出，所申请的2008年度氟氯化碳数量中所列若干种药品似在2010年之前不会重新改制。
它们建议，这就涉及到了以下问题：可否把所涉各项提名和数量视为必要用途。
While recommending the nominations noted above, the Panel notes that several of the drugs included in the CFC quantities requested for 2008 might not be reformulated before 2010, and they suggest that this raises the question of whether related nominations and quantities can be considered to be essential.
技经评估组还建议，综合产品旨在为病人提供方便、以及出于商业方面的考虑，因此似不应视为必要用途。
The Panel also suggests that combination products are used for patient convenience and commercial considerations and may therefore not be considered to be essential.
最后，技经评估组强调说，对库存的管理将继续具有重大意义，以期避免不必要的的氟氯化碳生产、以及潜在的过分销毁的必要性。
Finally, the Panel emphasizes that management of stockpiles will continue to be extremely important to avoid unnecessary production of CFCs and the potential need for excessive destruction.
在此问题上，技经评估组建议说，各缔约方或愿考虑汇报其1996年之前的库存、以及要求在其今后的提名中列入使用或处置库存方面的计划所具有的种种益处。
In that regard, it suggests that the Parties may wish to consider the reporting of pre-1996 stocks and the advantages of requiring that plans for use or disposal of stockpiles be included in future nominations.
有关计量吸入器的必要用途提名已在技术和经济评估小组2007年进度报告的第一章中作了讨论。
Essential-use nominations for metered-dose inhalers are discussed in chapter 1 of the Technology and Economic Assessment Panel's 2007 progress report.
7．除上述计量吸入器方面的必要用途豁免申请之外，俄罗斯联邦还申请分别于2008和2009年间豁免140吨氟氯化碳-113和130吨氟氯化碳-113，用于某些空间应用。
In addition to the essential-use exemption requests for metered-dose inhalers noted above, the Russian Federation requested an exemption for the use of 140 tonnes of CFC-113 for 2008 and 130 tonnes for 2009 for certain aerospace applications.
缔约方或愿回顾，缔约方曾在其第XVIII/8号决定中核可了2007年度的此方面的必要用途豁免。
当时缔约方曾请技术和经济评估小组与化学品技术选择委员会携手，并与俄罗斯联邦合作进行一项综合评估，以确定可用于此方面用途的现有氟氯化碳-113替代品。
The Parties may remember that in decision XVIII/8, in which they approved a 2007 essential-use exemption for this use, the Technology and Economic Assessment Panel was asked to work with its Chemicals Technical Options Committee, in cooperation with the Russian Federation, to undertake a comprehensive assessment to determine if existing alternatives to CFC-113 could be employed for this use.
该项决定还请俄罗斯联邦进一步考虑，它是否可使用来那些自国外的、被确定为可用于满足此方面的今后需要的来源的氟氯化碳-113库存。
That decision also requested the Russian Federation to consider further if it could use foreign sources of CFC-113 stockpiles that had been identified as a contribution to meeting any future needs for this use.
8．技经评估组在其2007年进度报告的第4.4节中探讨了以上第7段中所列述的各项议题。
技经评估组在该节中注意到化学品技术选择委员会的意见，即虽然氟氯烃-225可用作俄罗斯联邦的一些用途的替代品，但这仅仅只能作为一种临时解决办法。
The Panel addresses the issues discussed in paragraph 7 above in section 4.4 of its 2007 progress report, in which it notes the view of its Chemicals Technical Options Committee that while HCFC-225 may be used as an alternative for some of the Russian uses, this would serve as only a temporary solution.
为此，经对俄罗斯联邦所提议的过渡期情况进行审查后，技经评估组建议核可俄罗斯联邦2008和2009年度的豁免申请。
Accordingly, and after a review of the proposed transition of the Russian Federation, the Panel recommends approval of the requests of the Russian Federation for 2008 and 2009.
同时，技经评估组还鼓励俄罗斯联邦继续探求从全球库存市场上进口它所需要的氟氯化碳-113的可能性，从而使之无需使用新生产的氟氯化碳-113。
In so doing, it encourages the Russian Federation to continue to explore the possibility of importing the CFC-113 it needs from available global stocks so that it will not be necessary to use newly manufactured CFC-113.
2． 项目4 (b): 技术和经济评估小组及执行委员会审查在减少源自和使用作为加工剂的消耗臭氧物质的排放、以及实施减排技术和替代性工艺及产品方面所取得的进展（第XVII/6号决定）
Item 4 (b): Technology and Economic Assessment Panel and Executive Committee review of progress made in reducing emissions from and the use of ozone depleting substances as process agents, and the implementation of emission reduction techniques and alternative processes and products (decision XVII/6)
9．依照第XVII/6号决定，缔约方请技术和经济评估小组及执行委员会向不限成员名额工作组第二十七次会议汇报在减少来自加工剂用途的排放方面所取得的进展、与之相关的受控物质的构成及其数量、实施和制订减排工艺和替代工艺、以及不使用耗氧物质的替代工艺和产品。
In accordance with decision XVII/6, the Technology and Economic Assessment Panel and the Executive Committee are requested to report to the Open-ended Working Group at its twenty-seventh meeting on progress made in reducing emissions of controlled substances from process agent uses, the associated make-up and quantity of controlled substances and the implementation and development of emission reduction techniques and alternative processes and products not using ozone-depleting substances.
技经评估组未针对这一议题进行单独的研究，但执行委员关于这一事项的报告将在编制完毕后尽快发送给各缔约方。
The Panel did not carry out a separate study on this issue, but the Executive Committee's report on it will be dispatched to the Parties as soon as it is available.
10．第XVII/6号决定还要求在2008年的缔约方第二十次会议上、以及其后每隔一年,应由技术和经济评估小组针对以下事项作出汇报和提出建议：加工剂用途的豁免问题、与任何此种用途有关的重大排放问题、以及可增列入第X/14号决定表A或从中予以删除的加工剂用途。
Decision XVII/6 also requested that beginning at the Twentieth Meeting of the Parties, in 2008, and every other year thereafter, the Technology and Economic Assessment Panel report and make recommendations on process agent use exemptions, on insignificant emissions associated with any such use and process agent uses that could be added to or deleted from table A of decision X/14.